Search Results - "Tanriover, B."

Kidneys at Higher Risk of Discard: Expanding the Role of Dual Kidney Transplantation by Tanriover, B., Mohan, S., Cohen, D. J., Radhakrishnan, J., Nickolas, T. L., Stone, P. W., Tsapepas, D. S., Crew, R. J., Dube, G. K., Sandoval, P. R., Samstein, B., Dogan, E., Gaston, R. S., Tanriover, J. N., Ratner, L. E., Hardy, M. A.

“…Half of the recovered expanded criteria donor (ECD) kidneys are discarded in the United States. A new kidney allocation system offers kidneys at higher risk of…”
Get full text

Reduced Fracture Risk With Early Corticosteroid Withdrawal After Kidney Transplant by Nikkel, L. E., Mohan, S., Zhang, A., McMahon, D. J., Boutroy, S., Dube, G., Tanriover, B., Cohen, D., Ratner, L., Hollenbeak, C. S., Leonard, M. B., Shane, E., Nickolas, T. L.

“…Corticosteroid use after kidney transplantation results in severe bone loss and high fracture risk. Although corticosteroid withdrawal in the early…”
Get full text

Does Induction Therapy for Heart Transplant Recipients on Tacrolimus/Mycophenolate/Prednisone Improve Survival in the Current Allocation Era? by Amin, A.A, Ariyamuthu, V.K, Urey, M.A, Araj, F.G, Drazner, M.H, Mammen, P.P, Tanriover, B

Get full text

Survival with Induction Therapy for Simultaneous Heart-Kidney Transplant Recipients on Tacrolimus/Mycophenolate by Amin, A.A, Ariyamuthu, V.K, Urey, M.A, Araj, F.G, Drazner, M.H, Mammen, P.P, Tanriover, B

Get full text

Availability, Utilization and Outcomes of Deceased Diabetic Donor Kidneys; Analysis Based on the UNOS Registry by Mohan, S., Tanriover, B., Ali, N., Crew, R. J., Dube, G. K., Radhakrishnan, J., Hardy, M. A., Ratner, L. E., McClellan, W., Cohen, D.

“…The number of kidneys obtained from deceased diabetic donors available for transplantation has increased >eightfold increase in the past 15 years. We assessed…”
Get full text

Estimating Waiting Time for Deceased Donor Renal Transplantion in the Era of New Kidney Allocation System by Torlak, F, Ayvaci, M.U.S, Ahsen, M.E, Arce, C, Vazquez, M.A, Tanriover, B

“…Abstract Background On December 4, 2014, a new deceased donor kidney allocation system (KAS) was implemented. The KAS was designed to improve organ equity and…”
Get full text

Aseptic meningitis and abducens nerve palsy as a serious side effect of high dose intravenous immunoglobulin used in a patient with renal transplantation by Wright, S.E., Shaikh, Z.H.A., Castillo‐Lugo, J.A., Tanriover, B.

“…: Immune globulin intravenous (human) (IGIV) is effective in the treatment of various autoimmune and inflammatory disorders. Recently, high‐dose IGIV 2 g/kg…”
Get full text

High-Dose Intravenous Immunoglobulin and Rituximab Treatment for Antibody-Mediated Rejection After Kidney Transplantation: A Cost Analysis by Tanriover, B, Wright, S.E, Foster, S.V, Roush, K.S, Castillo-Lugo, J.A, Fa, K, Levy, F.L, Mejia, A

“…Abstract Antibody-mediated rejection (AMR) generally occurs in highly sensitized patients. A pilot study was performed on 7 consecutive patients with AMR to…”
Get full text

2013 Banff Criteria for Acute Antibody-Mediated Rejection Are Superior to 2007 Banff Criteria in the Diagnosis and Assessment of Renal Allograft Outcomes by Hassler, Jared, Tanriover, Bekir, Ariyamutu, Venkatesh, Burguete, Daniel, Hendricks, Allen R., Torrealba, Jose R.

“…The 2013 Banff meeting updated the requirements for the diagnosis of acute/active antibody-mediated rejection (AAMR) in kidney allografts. There has been…”
Get full text

RENAL BIOPSY IN LIVER TRANSPLANT CANDIDATES: 1233 by Tanriover, B., Cohen, D. J., Ratner, L.

Get full text

Feasibility of Endoscopic Allograft Duodenal Biopsy Following Pancreatic Transplantation: 1691 by Gonda, T., Sandoval, R., Camacho-Rivera, J., Watkins, A., Tanriover, B., Ratner, L. E.

Get full text

Preformed Donor-Specific Antibodies and Risk of Antibody-Mediated Rejection in Repeat Renal Transplantation by Tsapepas, D S, Vasilescu, R, Tanriover, B, Coppleson, Y, Rekhtman, Y, Hardy, M A, Dube, G, Crew, R J, Ratner, L E, Cohen, D J, Mohan, S

“…Many factors are associated with poorer graft outcome after transplantation: acute rejection, HLA matching, degree of sensitization and re-transplantation…”
Get full text

Improvement in 3-Month Patient-Reported Gastrointestinal Symptoms After Conversion From Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium in Renal Transplant Patients by BOLIN, Paul, TANRIOVER, Bekir, ZIBARI, Gazi B, LYNN, Melissa L, PIRSCH, John D, CHAN, Laurence, COOPER, Matthew, LANGONE, Anthony J, TOMLANOVICH, Stephen J

“…The benefit of conversion from mycophenolate mofetil (MMF) to enteric-coated mycophenolate sodium (EC-MPS) in terms of gastrointestinal symptom burden has been…”
Get full text

Analysis of Kidney Function and Biopsy Results in Liver Failure Patients With Renal Dysfunction : A New Look to Combined Liver Kidney Allocation in the Post-MELD Era by TANRIOVER, Bekir, MEJIA, Alejandro, WEINSTEIN, Jeffrey, FOSTER, Steven V, GHALIB, Reem, MUBARAK, Abdullah, CHENG, Stephen S

“…Renal dysfunction in the context of liver failure negatively impacts orthotopic liver transplantation (OLT) outcomes. Appropriate allocation of combined liver…”
Get full text

PERFORMANCE OF CHRONIC KIDNEY DISEASE EPIDEMIOLOGY COLLABORATION (CKD-EPI) FORMULA AND INULIN BASED GLOMERULAR FILTRATION RATE EQUATION (IB-EGFR) AGAINST IOTHALAMATE PLASMA URINE CLEARANCE AND 24 HOUR URINE CREATININE CLEARANCE MEASUREMENT IN LIVE DONOR NEPHRECTOMY EVALUATION: 1236 by Tanriover, B., Ghanta, M., Cohen, D. J., Ratner, L., Nicholas, T. L.

Get full text

CLINICAL USE OF GLOMERULAR FILTRATION RATE (GFR) ESTIMATES FOR LIVE DONOR NEPHRECTOMY: 2837 by Tanriover, B., Cohen, D. J., Ghanta, M., Ratner, L., Nicholas, T. L.

Get full text

Bacteremia associated with tunneled dialysis catheters: Comparison of two treatment strategies by Tanriover, Bekir, Carlton, Donna, Saddekni, Souheil, Hamrick, Kay, Oser, Rachel, Westfall, Andrew O., Allon, Michael

“…Bacteremia associated with tunneled dialysis catheters: Comparison of two treatment strategies. Tunneled dialysis catheters are often used for temporary…”
Get full text

Impact of Small Variations in the Delivered Dose of Rabbit Antithymocyte Induction Therapy in Kidney Transplantation With Early Corticosteroid Withdrawal by TSAPEPAS, Demetra S, MOHAN, Sumit, TANRIOVER, Bekir, DUBE, Geoffrey, CREW, R. John, COHEN, David J, HARDY, Mark A, SANDOVAL, P. Rodrigo, RATNER, Lloyd E

“…Optimal dosing of rabbit antithymocyte globulin (rATG) induction therapy in kidney transplantation is not well defined. The impact of dosing from variations in…”
Get full text

Screening asymptomatic diabetic patients for coronary artery disease prior to renal transplantation by RAMANATHAN, Venkataraman, GORAL, Simin, TANRIOVER, Bekir, FEURER, Irene D, KAZANCIOGLU, Rumeyza, SHAFFER, David, HELDERMAN, J. Harold

“…Coronary artery disease (CAD) is a significant contributor to excess mortality in renal transplant candidates with diabetes mellitus (DM). Prior studies…”
Get full text

Polyclonal antibody-induced serum sickness in renal transplant recipients : Treatment with therapeutic plasma exchange by TANRIOVER, Bekir, CHUANG, Peak, FISHBACH, Bernard, HELDERMAN, J. Harold, KIZILISIK, Tarik, NYLANDER, William, SHAFFER, David, LANGONE, Anthony J

“…Serum sickness is an immune-complex mediated illness that frequently occurs in patients after polyclonal antibody therapy (ATGAM or thymoglobulin). Serum…”
Get full text